Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML

Matthieu Duchmann et al.
Blood Cancer Journal

Recent data suggest that NPM1-mutated AMLs are heterogeneous in terms of co-mutations and expression of transcriptomic programs and surface proteins. Such heterogeneity may reflect a variable differentiation blockade of leukemic cells. Indeed, blasts in some NPM1-mutated AMLs may display an immature progenitor morphology, immunophenotype, and transcriptional program, or have a more mature monocytic and/or dendritic differentiation in other patients. These differences can be clinically important, as immature blasts might have higher stemness capacity, a feature associated with poorer outcomes in AML. Conversely, blasts with monocytic differentiation may have immunosuppressive capacities, and relative BCL-2 independence. Previous reports based on bulk sequencing revealed only weak associations between NPM1/FLT3-ITD genotype and immature phenotype and between NPM1/FLT3-TKD or NPM1/RAS genotypes and monocytic/dendritic differentiation. Novel technologies allow simultaneous genotyping and analysis of surface protein expression at single-cell resolution and may help to resolve the interconnection between genotype and cell differentiation in leukemia. We used a droplet-based multi-omics single-cell platform to characterize the genetic clonal architecture in eleven NPM1-mutated AML diagnostic samples and investigate the relationship between co-mutations and phenotypic hematologic differentiation at the single-cell level.


Matthieu Duchmann


Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative Neoplasms
Luque Paz, Damien
Massively parallel base editing to map variant effects in human hematopoiesis
Jorge D. Martin-Rufino
Spectrum of clonal hematopoiesis in VEXAS syndrome
Fernanda Gutierrez-Rodrigues
Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells
Inge van der Werf
Cell Reports Medicine